Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00467363 · ClinicalTrials.gov registry record · NA
The Effects of Aspirin in Gestation and Reproduction
A NA study, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- Completed
- Registry status
- NA
- Development phase
- 1,228
- Enrollment target
NCT00467363: Completed NA study, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
NCT00467363 is a NA study that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 1,228 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (13% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00467363, a NA study, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
- COMPLETED
- Registry status
- NA
- Development phase
- 1,228 participants
- Enrollment target
Study Summary
The primary objective of the study is to help elucidate the effects of low-dose aspirin in combination with folic acid on the incidence of live births and spontaneous abortions among a group of women who become pregnant compared to a control group.
Primary Outcome
Live birth was obtained prospectively by maternal report and abstraction from medical records by trained staff .
Interventions
- DIETARY_SUPPLEMENT Folic acid
- DRUG acetylsalicylic-acid (aspirin)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,228 participants |
| Start Date | 2007-06 |
| Est. Completion | 2012-07 |
| Phase | NA |
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)305 total trials
What the finished NCT00467363 record still lists
NCT00467363 is an interventional study that assigns participants to a tested intervention. Its 1,228 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (13% lower).
The record links to 0 conditions, and to 2 interventions - of which Folic acid is the first listed.
NCT00467363 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00467363 about?
NCT00467363 is a clinical study titled "The Effects of Aspirin in Gestation and Reproduction". The primary objective of the study is to help elucidate the effects of low-dose aspirin in combination with folic acid on the incidence of live births and spontaneous abortions among a group of women who become pregnant compared to a control group.
What is the current status of trial NCT00467363?
This trial is currently completed. It is a NA study. The enrollment target is 1,228 participants. The study started on 2007-06. Estimated completion is 2012-07.
What interventions are being tested in trial NCT00467363?
The interventions under investigation include: Folic acid (DIETARY_SUPPLEMENT), acetylsalicylic-acid (aspirin) (DRUG).
Who is sponsoring clinical trial NCT00467363?
This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00467363's enrollment target sits among peer trials
1,228 83rd of 2000 higher than 1,918 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05946044 · 1,230 participants · NA
The Osteoarthritis Prevention Study
- NCT06787937 · 1,230 participants · NA
Communicating About Nicotine Reduction in Cigarettes
- NCT05456841 · 1,232 participants · NA
Empathic Communication Skills (ECS) Training
- NCT06921785 · 1,220 participants · Phase 3
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia